Lipigon Pharmaceuticals AB (FRA:9RP) Pretax Margin %: % (As of Dec. 2025)

What is Lipigon Pharmaceuticals AB Pretax Margin %?

Lipigon Pharmaceuticals AB FRA:9RP Pretax Margin % is % as of Dec. 2025. The stock has 2 warning signs investors should review. Among 939 Biotechnology companies, Lipigon Pharmaceuticals AB ranks worse than 106496.17% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Lipigon Pharmaceuticals AB's Pre-Tax Income for the three months ended in Dec. 2025 was €-0.66 Mil. Lipigon Pharmaceuticals AB's Revenue for the three months ended in Dec. 2025 was €0.00 Mil. Therefore, Lipigon Pharmaceuticals AB's pretax margin for the quarter that ended in Dec. 2025 was %.

The historical rank and industry rank for Lipigon Pharmaceuticals AB's Pretax Margin % or its related term are showing as below:

FRA:9RP's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -89.42
* Ranked among companies with meaningful Pretax Margin % only.

Lipigon Pharmaceuticals AB (FRA:9RP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Lipigon Pharmaceuticals AB Pretax Margin % Related Terms

Lipigon Pharmaceuticals AB Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Lipigon Pharmaceuticals AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipigon Pharmaceuticals AB Pretax Margin % Chart

Lipigon Pharmaceuticals AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Pretax Margin %

Get a 7-Day Free Trial

-1,291.29

0.00

-73.89

-245.64

0.00

Lipigon Pharmaceuticals AB Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Pretax Margin %	Get a 7-Day Free Trial															-809.57	0.00	0.00	0.00	0.00

FRA:9RP vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Lipigon Pharmaceuticals AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lipigon Pharmaceuticals AB Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipigon Pharmaceuticals AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Lipigon Pharmaceuticals AB's Pretax Margin % falls into.

Save Embed

Lipigon Pharmaceuticals AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Lipigon Pharmaceuticals AB's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-2.981	/	0
	=	%

Lipigon Pharmaceuticals AB's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-0.66	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

Lipigon Pharmaceuticals AB (FRA:9RP) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Lipigon Pharmaceuticals AB and its competitors. According to the industry distribution chart, Lipigon Pharmaceuticals AB ranks #999999 out of 939 companies in the Biotechnology industry.

Is Lipigon Pharmaceuticals AB's Pretax Margin % too high?

Lipigon Pharmaceuticals AB's current Pretax Margin % is %. Based on the distribution chart, Lipigon Pharmaceuticals AB ranks #999999 out of 939 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.

How does Lipigon Pharmaceuticals AB's Pretax Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Lipigon Pharmaceuticals AB ranks #999999 out of 939 companies for Pretax Margin %. This places Lipigon Pharmaceuticals AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Lipigon Pharmaceuticals AB and its competitors. Lipigon Pharmaceuticals AB's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Lipigon Pharmaceuticals AB stock overvalued right now?

Lipigon Pharmaceuticals AB (FRA:9RP) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Lipigon Pharmaceuticals AB (FRA:9RP), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lipigon Pharmaceuticals AB Business Description

Industry Healthcare Biotechnology

Comparable Companies FRA:T5O VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX INCY INSM HKSE:02269 ASND HKSE:01801

Address Tvistevagen 48 C, Umea, SWE, 90736

Website https://www.lipigon.se

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.